These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5859471)

  • 21. [Influence of premedication with gibberellic acid on the growth of subcutaneously transplanted Ehrlich ascites tumor].
    Schwartz E
    Z Krebsforsch; 1968; 71(1):16-20. PubMed ID: 4233393
    [No Abstract]   [Full Text] [Related]  

  • 22. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
    Terlikowski S; Sulkowska M; Nowak HF
    J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of detergents on the growth of Ehrlich ascites carcinomas].
    Hanson H; Bohley P
    Z Krebsforsch; 1968; 71(1):51-8. PubMed ID: 4233396
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

  • 26. IMMUNITY AND ANTIBODY FORMATION INDUCED BY INTRAPERITONEAL OR SUBCUTANEOUS INJECTION OF KREBS-2 ASCITES TUMOR CELLS TREATED WITH INFLUENZA VIRUS.
    EATON MD; LEVINTHAL JD; SCALA AR; JEWELL ML
    J Natl Cancer Inst; 1965 May; 34():661-72. PubMed ID: 14313824
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological protection mechanisms of radioprotectors in mammalian cells. 8. Mitotic behavior in the cell cycle of normal Ehrlich ascites tumor cells and those treated with MEA using the 8-azaguanine method.
    Kobayashi J; Kawamura F
    Tokushima J Exp Med; 1966 Aug; 13(1-2):35-42. PubMed ID: 5957666
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of the effective dose for the in-vitro destruction of Ehrlich mice ascites carcinoma cells by nitrogen mustard oxide].
    von Ardenne M; Reitnauer PG
    Acta Biol Med Ger; 1966; 16(1):43-53. PubMed ID: 5974487
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the effect of mitomes and roentgen rays on the ascites cells of Ehrlich mouse carcinoma].
    Becker HD; Strassner W; Fischer H
    Radiobiol Radiother (Berl); 1965; 6(4):467-75. PubMed ID: 5828659
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the problem of diurnal rhythm variations of radiation sensitivity in tumor-bearing mice and control animals].
    Fochem K; Michalica W; Picha E
    Strahlentherapie; 1966 Aug; 130(4):590-4. PubMed ID: 5996859
    [No Abstract]   [Full Text] [Related]  

  • 31. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE USEFULNESS OF TISSUE CULTURE CELL LINES IN THE DEVELOPMENT OF ASCITES TUMORS FROM A TRANSPLANTABLE SQUAMOUS CELL MOUSE CARCINOMA.
    FERNANDES MR; KOPROWSKA I
    Cancer Res; 1965 May; 25():444-9. PubMed ID: 14297480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cell division in Ehrlich ascites tumor and survival of mice after administration of chalone].
    Savchenko TV; Zakharov VB; Mamontov SG; Romanov IuA
    Vestn Akad Med Nauk SSSR; 1980; (11):54-9. PubMed ID: 6451996
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological protection mechanisms of radio-protectors in mammalian cells. IX. Mitotic behavior in the cell cycle of normal Ehrlich ascites tumor cells and those treated with AET using the 8-azaguanine method.
    Kobayashi J; Kawamura F
    Tokushima J Exp Med; 1966 Aug; 13(1-2):43-51. PubMed ID: 5957667
    [No Abstract]   [Full Text] [Related]  

  • 35. [Change of blue and ultraviolet fluorescence of cells of Ehrlich ascites carcinoma during mitosis].
    Buze EG; Astashina TP
    Izv Akad Nauk SSSR Biol; 1965; 6():935-6. PubMed ID: 5896294
    [No Abstract]   [Full Text] [Related]  

  • 36. Deoxycytidylate aminohydrolase in cells of Ehrlich ascites tumour.
    Mangoni di Stefano C
    Enzymologia; 1969 Jan; 36(1):25-30. PubMed ID: 5796793
    [No Abstract]   [Full Text] [Related]  

  • 37. Aspects of chalone action.
    Lehmann W; Graetz H; Schunck H; Schütt M; Langen P
    Acta Histochem Suppl; 1983; 27():63-71. PubMed ID: 6223337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intraperitoneal administration of FT-207 for mouse peritonitis carcinomatosa].
    Kurokawa T; Iwasa H; Mimura K; Terashima H; Hiraide H; Mizoguchi O; Kanabe S; Tamaki K; Kadota T; Hatsuse K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):881-7. PubMed ID: 6426398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stimulation of cell division by Ehrlich carcinoma cell surface antibodies].
    Segarra M; Alfonso M; Subiza JL; Coll J
    Rev Esp Oncol; 1984; 31(2):205-13. PubMed ID: 6443683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.